Navigation Links
Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
Date:7/11/2012

to activate sites and conduct the Light Study; the potential for, and timing of, the accrual of MACE events and the potential resubmission of the Contrave NDA; the safety and effectiveness of Contrave; and the potential for, and timing of, approval for Contrave. The inclusion of forward-looking statements should not be regarded as a representation by Orexigen that any of its plans will be achieved. Actual results may differ from those set forth in this release due to the risk and uncertainties inherent in the Orexigen business, including, without limitation: the Special Protocol Assessment (SPA) is not binding on the FDA if public health concerns unrecognized at the time the SPA agreement was entered into become evident, other new scientific concerns regarding product safety or efficacy arise, or if Orexigen fails to comply with the agreed upon trial protocol; Orexigen's ability to conduct the Light Study and the progress and timing thereof, including risks associated with recruiting and enrolling patients in the Light Study; Orexigen's ability to demonstrate in the Light Study that the risk of MACE in overweight and obese subjects treated with Contrave does not adversely affect the product candidate's benefit-risk profile; the potential that earlier clinical trials may not be predictive of future results in the Light Study; the potential for the FDA to not approve Contrave even after the resubmission with the MACE event data; the potential for early termination of the collaboration agreement between Orexigen and Takeda; the costs and time required to complete additional clinical, non-clinical or other requirements prior to any resubmission of an NDA; the therapeutic and commercial value of Contrave; Orexigen's ability to maintain sufficient capital; and other risks described in the Company's filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof,
'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
4. NIPTE Will Participate in NIHs Therapeutics for Rare and Neglected Diseases (TRND) Program
5. Frost & Sullivan: European Bipolar Therapeutics Market Slows Down in the Short Term As Key Blockbuster Drugs Go Off Patent
6. Oncos Therapeutics Announces Clinical Advisory Board for its Oncolytic Virus and Cancer Immunotherapy Development Programs
7. The New Generation of Antibody Therapeutics: Current Status and Future Prospects - Overview
8. Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020
9. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
10. Novelos Therapeutics to Present at LHA Life Sciences & Medical Technologies Virtual Conference on June 28
11. Faruqi & Faruqi, LLP is Investigating Pain Therapeutics Inc. on Behalf of its Shareholders (PTIE)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... 14, 2014 The legalization of medical and ... well as a new economic driver – that has ... out the right response to the will of the ... At a National Press Club Newsmakers news ... leading experts in the area of marijuana legalization will ...
(Date:7/14/2014)... 14 de julio de 2014 /PRNewswire-HISPANIC PR WIRE/ -- ... Barry Epling , presidente de la junta directiva, ... la Compañía. El señor Epling es el dueño de ... la licencia de su formulación, sus propiedades intelectuales y ... apoyo financiero. "El señor Gerald Epling ...
(Date:7/14/2014)... PARK, Colo. , July 14, 2014 /PRNewswire-iReach/ -- Harmony ... center, located in Estes Park , will ... July 18, 2014 at 10:00 am on Harmony,s campus. The ... The building is part of Harmony,s $10 million ... capacity to address the growing and complex addiction rates in ...
Breaking Medicine Technology:NPC Newsmaker Program: Interpreting smoke signals from the marijuana skirmish line 2BioAdaptives se prepara para el próximo paso 2BioAdaptives se prepara para el próximo paso 3Harmony Foundation Breaking Ground on Addiction Health Center 2
... 8, 2011 /PRNewswire-Asia/ -- To thank customers for their ... infrared thermometers , heart beat watches, blood pressure monitors ... has decided to offer these products with discounts ... market needs and offer more suitable products to customers, ...
... 2011 SANYO North America Corporation (SANYO) ... Station (CPWS), an integrated, stand-alone solution for GMP compliant ... therapies for research use, has been installed at the ... first installation of the CPWS, as well as marking ...
Cached Medicine Technology:SANYO Installs First Cell Processing Work Station in the United States at University of Alabama at Birmingham 2SANYO Installs First Cell Processing Work Station in the United States at University of Alabama at Birmingham 3
(Date:7/14/2014)... 2014 Acute coronary syndrome (ACS) ... healthcare costs, frequent recurrences and hospitalizations, and high ... ACS incidence increases with age and will be ... population increases around the world. ACS is classified ... heart muscle damage inferred from a person’s symptoms, ...
(Date:7/14/2014)... 2014 Midway through summer, throngs of families ... the National Lampoon classic “Vacation.” An estimated four out of ... by Bridgestone Americas , embark on summer road trips. And ... nagging back pain as the result of hours cramped behind ... , “For these patients, riding in a car for an ...
(Date:7/14/2014)... Institutes of Health (NIH) have identified genetic markers associated ... characterized by high levels of immune cells called eosinophils ... are involved in the development of EoE, which can ... allergies. The findings also may help explain why the ... in part by the Consortium of Food Allergy ...
(Date:7/14/2014)... A recent study published in the July 2014 ... of Child and Adolescent Psychiatry confirms the validity ... criterion for diagnosis of attention-deficit/hyperactivity disorder (ADHD). , In ... at 7 in DSM-IV, has been raised to 12. ... set at 12, rather than an earlier age, to ...
(Date:7/14/2014)... years that have passed since acupuncture was first ... used to treat a number of physical, mental ... rehabilitation, headaches, menstrual cramps, asthma, carpal tunnel, fibromyalgia ... Now, a meta-analysis of randomized controlled trials which ... , the journal of The North American Menopause ...
Breaking Medicine News(10 mins):Health News:Acute Coronary Syndrome (ACS) Incident Cases to Reach 1.47 million by 2023, Says a New Report Available at ReportsnReports.com 2Health News:Acute Coronary Syndrome (ACS) Incident Cases to Reach 1.47 million by 2023, Says a New Report Available at ReportsnReports.com 3Health News:Acute Coronary Syndrome (ACS) Incident Cases to Reach 1.47 million by 2023, Says a New Report Available at ReportsnReports.com 4Health News:Top Orthopedic Surgeon Shares Seven Ways To Reduce Back Pain During Long Summer Road Trips 2Health News:Top Orthopedic Surgeon Shares Seven Ways To Reduce Back Pain During Long Summer Road Trips 3Health News:Scientists deepen genetic understanding of eosinophilic esophagitis 2Health News:Bothered by hot flashes? Acupuncture might be the answer 2
... and his colleagues from the Stanford University School of Medicine ... Cancer Research. The result of the study has found that ... to reduce the growth of cancer in patients with prostate ... two drugs reduces the growth of prostate cancer by 70 ...
... researchers from University of South Florida had reported in ... Sciences that the more nature of mental exercise performed ... reducing the risk of dementia in later life.// ... lifetime occupation and risk for Alzheimer’s disease and dementia ...
... Kolkata (6th Sept 2005): In an alarming announcement the ... that West Bengal was facing a Dengue epidemic and the ... last year.// ,Mishra also said that other than ... the people, especially in Kolkata. ,Dengue was also ...
... low dose of Vitamin D with non-steroidal anti- inflammatory ... says a study.// ,David Feldman and other researchers ... a form of Vitamin D, combined with an over-the-counter ... online edition of Ivanhoe Broadcast News. ,The researchers ...
... of had discovered a new way to test the ... attack. // ,The researchers had used a ... cells’ destinations after being injected into the body to ... attack. ,In the study, researchers surgically ...
... from anorexia nervosa have the similar brain activities that ... study was published in the September issue of Archives ... alterations in the activity of serotonin (a brain chemical ... the appetite alteration in anorexia nervosa as well as ...
Cached Medicine News:
... Selecta Duo Adding the ... platform creates the Selecta Duo, ... nm Photocoagulator combination laser that ... involving both the anterior segment ...
Patient-Centered Therapy that promotes natural cardiac function....
... The Apeel CS Catheter Delivery System ... used for the placement of permanent ... Apeel CS Catheter Delivery System is ... torqueability, flexibility, and softness, plus high ...
... Alliance Catheter Delivery System (CDS) ... stabilization of the Aescula LV ... has a patented coronary sinus ... and easy access to the ...
Medicine Products: